Israeli biotech BioView’s cancer scanning systems will be integrated with French company ScreenCell’s technology to isolate rare tumour cells. The combined solution will improve diagnosis and speed up medical decisions about the best treatment options.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000764005&fid=1725